Literature DB >> 25304929

Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database.

Emma H Allott1, Lauren E Howard2, Matthew R Cooperberg3, Christopher J Kane4, William J Aronson5, Martha K Terris6, Christopher L Amling7, Stephen J Freedland8.   

Abstract

BACKGROUND: Evidence for an association between total cholesterol, low- and high-density lipoproteins (LDL and HDL, respectively), triglycerides, and prostate cancer is conflicting. Given that prostate cancer and dyslipidemia affect large proportions of Western society, understanding these associations has public health importance.
METHODS: We conducted a retrospective cohort analysis of 843 radical prostatectomy (RP) patients who never used statins before surgery within the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Multivariable Cox proportional hazards analysis was used to investigate the association between cholesterol, LDL, HDL, and triglycerides and biochemical recurrence risk. In secondary analysis, we explored these associations in patients with dyslipidemia, defined using National Cholesterol Education Program guidelines.
RESULTS: Elevated serum triglycerides were associated with increased risk of prostate cancer recurrence [HRper 10 mg/dl, 1.03; 95% confidence interval (CI), 1.01-1.05] but associations between total cholesterol, LDL and HDL, and recurrence risk were null. However, among men with dyslipidemia, each 10 mg/dl increase in cholesterol and HDL was associated with 9% increased recurrence risk (HR, 1.09; 95% CI, 1.01-1.17) and 39% reduced recurrence risk (HR, 0.61; 95% CI, 0.41-0.91), respectively.
CONCLUSIONS: Elevated serum triglycerides were associated with increased risk of prostate cancer recurrence. Cholesterol, LDL, or HDL were not associated with recurrence risk among all men. However, among men with dyslipidemia, elevated cholesterol and HDL levels were associated with increased and decreased risk of recurrence, respectively. IMPACT: These findings, coupled with evidence that statin use is associated with reduced recurrence risk, suggest that lipid levels should be explored as a modifiable risk factor for prostate cancer recurrence. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25304929      PMCID: PMC4221498          DOI: 10.1158/1055-9965.EPI-14-0458

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  32 in total

1.  Statins and prostate cancer diagnosis and grade in a veterans population.

Authors:  Wildon R Farwell; Leonard W D'Avolio; Richard E Scranton; Elizabeth V Lawler; J Michael Gaziano
Journal:  J Natl Cancer Inst       Date:  2011-04-15       Impact factor: 13.506

Review 2.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Richard Kahn; John Buse; Ele Ferrannini; Michael Stern
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

3.  Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.

Authors:  Emma H Allott; Lauren E Howard; Matthew R Cooperberg; Christopher J Kane; William J Aronson; Martha K Terris; Christopher L Amling; Stephen J Freedland
Journal:  BJU Int       Date:  2014-05-08       Impact factor: 5.588

4.  Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer.

Authors:  Jiyoung Ahn; Unhee Lim; Stephanie J Weinstein; Arthur Schatzkin; Richard B Hayes; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

5.  Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway.

Authors:  Richard M Martin; Lars Vatten; David Gunnell; Pål Romundstad; Tom I L Nilsen
Journal:  Cancer Causes Control       Date:  2009-03-11       Impact factor: 2.506

Review 6.  Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective.

Authors:  James Robert Krycer; Andrew John Brown
Journal:  Biochim Biophys Acta       Date:  2013-01-26

7.  High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States.

Authors:  Janet L Colli; Christopher L Amling
Journal:  Urol Oncol       Date:  2008-02-04       Impact factor: 3.498

8.  The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region.

Authors:  Rachel Huxley; A Ansary-Mohaddam; R Huxley; F Barzi; T H Lam; K Jamrozik; T Ohkubo; X Fang; H J Sun; M Woodward; D F Gu; A Rodgers; Y Imai; W H Pan; I Suh; H J Sun; H Ueshima
Journal:  Asian Pac J Cancer Prev       Date:  2007 Apr-Jun

9.  Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort.

Authors:  Alison M Mondul; Sandra L Clipp; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-10-06       Impact factor: 2.506

10.  Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.

Authors:  Elahe A Mostaghel; Keith R Solomon; Kristine Pelton; Michael R Freeman; R Bruce Montgomery
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

View more
  49 in total

1.  Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade.

Authors:  Emanuela Taioli; William K Oh; Yixuan Gong; Li Wang; Haocheng Yu; Naomi Alpert; Mitchell D Cohen; Colette Prophete; Lori Horton; Maureen Sisco; Sung-Hyun Park; Hyun-Wook Lee; Judith Zelikoff; Lung-Chi Chen; Dana Hashim; Mayte Suarez-Farinas; Michael J Donovan; Stuart A Aaronson; Matthew Galsky; Jun Zhu
Journal:  Mol Cancer Res       Date:  2019-06-20       Impact factor: 5.852

2.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

Review 3.  Targeting intratumoral androgens: statins and beyond.

Authors:  Michael T Schweizer; Evan Y Yu
Journal:  Ther Adv Med Oncol       Date:  2016-05-11       Impact factor: 8.168

4.  Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.

Authors:  Emma H Allott; Lauren E Howard; Adriana C Vidal; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Stephen J Freedland
Journal:  Cancer Prev Res (Phila)       Date:  2017-05-09

5.  Pioglitazone Inhibits Periprostatic White Adipose Tissue Inflammation in Obese Mice.

Authors:  Miki Miyazawa; Kotha Subbaramaiah; Priya Bhardwaj; Xi Kathy Zhou; Hanhan Wang; Domenick J Falcone; Dilip D Giri; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2017-12-08

Review 6.  Obesity and cancer: mechanistic insights from transdisciplinary studies.

Authors:  Emma H Allott; Stephen D Hursting
Journal:  Endocr Relat Cancer       Date:  2015-09-15       Impact factor: 5.678

Review 7.  The Role of Cholesterol in Cancer.

Authors:  Omer F Kuzu; Mohammad A Noory; Gavin P Robertson
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

Review 8.  The Contribution of Cholesterol and Its Metabolites to the Pathophysiology of Breast Cancer.

Authors:  Amy E Baek; Erik R Nelson
Journal:  Horm Cancer       Date:  2016-03-28       Impact factor: 3.869

9.  Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.

Authors:  Emma H Allott; Lauren E Howard; William J Aronson; Martha K Terris; Christopher J Kane; Christopher L Amling; Matthew R Cooperberg; Stephen J Freedland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-25       Impact factor: 4.254

10.  Concentrated sugars and incidence of prostate cancer in a prospective cohort.

Authors:  Fayth L Miles; Marian L Neuhouser; Zuo-Feng Zhang
Journal:  Br J Nutr       Date:  2018-07-26       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.